gibreel ferishta's Library tagged medicines →  View Popular

Andhra Pradesh chief minister Y S Rajasekhara Reddy on Wednesday agreed for restructuring the government hospitals in the state in tune with the requirements of the Aarogyasri scheme, which provides cashless treatment to the poor.


Also Read

Related Stories

News Now
- India losing 2,000 patents every year: Jairam Ramesh
- YSR Reddy writes to McCarthy over attacks in Australia
- AP to set up Slum Rehab Authority
- Sabita Reddy is AP's first woman home minister
- YSR sworn in for second term
- YSR to resign as Andhra CM tomorrow

Also Read

Related Stories

News Now

- Sensex volatile; ACC down 4%
- NEWSALERT: Inflation in red, at -1.61%
- SpiceJet hikes fuel surcharge by Rs 400
- Most active stocks on the BSE
- Mahindra firm in volatile market; MHRIL IPO to open on June 23
- Asian markets in red; Hang Seng sheds 356pts
More

The health department prepared a blueprint for revamping the policies, support services, infrastructure and restructuring the staff of government hospitals.

The government proposed to increase the participation of government hospitals in the Aarogyasri programme from the present 9 per cent to 30 per cent in a year by creating better infrastructure and staff.

www.business-standard.com/...361328 - Preview

health pharmaceuticals pharma medicines drugs Andhra-pradesh

Medicines sold at government-set prices have become cheaper by nearly 3% after the country’s drug price regulator ordered a price cut
in the wake of the recent cut in excise duties.

The government last weekend announced a 4% cut in excise duties as part of a fiscal stimulus package to boost the economy. Various industries, most notably the automobile industry, have announced price cuts as companies look to pass on the benefits of the duty cut to consumers to boost demand.

The drug price regulator — the National Pharmaceutical Pricing Authority (NPPA) — notified the 2.84% price cut on Thursday and its decision is effective immediately. The price cut will cover about 17% of the Rs 45,000-crore domestic pharmaceutical market. The market segment affected by the price cuts has revenues of Rs 7,800 crore, industry officials say.

economictimes.indiatimes.com/...3825540.cms - Preview

pharma drugs price-control medicines excise NPPA